Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States

Background: While some studies among patients with HIV-1 suggest that antiretroviral therapy (ART) regimens containing tenofovir alafenamide (TAF) may be associated with greater weight gain than those not containing TAF, no studies have assessed the relationship between TAF doses and weight change....

Descripción completa

Detalles Bibliográficos
Autores principales: Emond, Bruno, Rossi, Carmine, Rogers, Rachel, Lefebvre, Patrick, Lafeuille, Marie-Hélène, Donga, Prina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843358/
https://www.ncbi.nlm.nih.gov/pubmed/35233432
http://dx.doi.org/10.36469/jheor.2022.31825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843358/
https://www.ncbi.nlm.nih.gov/pubmed/35233432
http://dx.doi.org/10.36469/jheor.2022.31825

Ejemplares similares